If you need more lookups,
subscriptions start at $34 USD/month.
Christine Probst Location
Seattle, WA, US
Christine Probst Work
Principal Scientist @ (September 2024 - Present)
Principal Technical Manager - Potency @ (March 2024 - September 2024)
Principal Scientist, Analytical Development CMC @ (March 2022 - December 2023)
Senior Scientist @ (October 2020 - March 2022)
Senior Scientist @ Amnis- part of Luminex (January 2019 - October 2020)
Research Scientist III @ (December 2012 - January 2018)
Graduate Research Assistant @ University of Washington (January 2010 - January 2012)
Christine Probst Education
University of Washington
Master of Science (MS) (Bioengineering and Biomedical Engineering)
2010-2012
UCLA
B.S. (Bioengineering)
2006-2010
Christine Probst Skills
Pre-clinical Studies
ICH
Common Technical Document (CTD)
Regulatory Submissions
Quality Control
GMP
CMC Regulatory Affairs
Analytical Methods Development
Immunoassays
Regulatory Development
Industry standards
Technical Documentation
Good Manufacturing Practice (GMP)
Capital Expenditures
T cells
Processes Development
Cryopreservation
Chemistry, Manufacturing, and Controls (CMC)
Bioengineering
Tissue Engineering
Cell Culture
Molecular Biology
Flow Cytometry
Microscopy
Tissue Culture
Biomedical Engineering
Microfabrication
Biomaterials
Fluorescence
Fluorescence Microscopy
Confocal Microscopy
Cell
Christine Probst Summary
Christine Probst, based in Seattle, WA, US, is currently a Principal Scientist at Bristol Myers Squibb. Christine Probst brings experience from previous roles at Genentech, Affini-T Therapeutics, KBI Biopharma and Amnis- part of Luminex. Christine Probst holds a 2010 - 2012 Master of Science (MS) in Bioengineering and Biomedical Engineering @ University of Washington. With a robust skill set that includes Pre-clinical Studies, ICH, Common Technical Document (CTD), Regulatory Submissions, Quality Control and more. Christine Probst has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Christine Probst?
Find contact details for 700 million professionals.